[ET Net News Agency, 20 June 2018] WuXi Biologics (Cayman) Inc. (02269) said its
controlling shareholder WuXi Biologics Holdings Limited has agreed to place 50 million
existing shares, representing about 4.08% of the total issued share capital, to
independent parties at HK$79.2 each.
Upon completion, the shareholding held by Biologics Holdings in WuXi Biologics will
decrease from about 59.43% to 55.34% and Biologics Holdings will remain as a controlling
shareholder. (HL)